Biotech company Galapagos improves high-co... Galapagoss mission is to develop first-in-class medicines based on the discovery of novel targets. Using human primary healthy andpatient cells, the company discovers which proteins play a key role … more ➔
Whitepaper Spotlight: Proactive Biomarker... Oncology drugs developed through a biomarker-guided precision medicine design are 38% more likely to be commercialized. But success relies on following a plan from the start — learn how in this … more ➔
LEA Jury announces the Winners of LEA 2019LEA, the Lipidomics Excellence Award, was founded to strengthen life sciences through lipidomics. Over the course of April, the LEA jury deliberated on the submitted projects to announce the three … more ➔
Inhibitor-free DNA Reliability for any... BioEcho develops single-spin and 96-well kits for the isolation of DNA. Their proprietary EchoLUTION single-step technology avoids the use of inhibitory process reagents resulting in increased sensitivity … more ➔
Reaching global markets Small- and medium-size European companies face the challenge of establishing global B2B activities in order to access relevant markets along the drug development value chain. YUMABs flexible business … more ➔
European Biotechnology Guide in its ninth... The 9th edition of the European Biotechnology Science & Industry Guide once more offers an interesting cross-section of the European biotech scene. more ➔
Eurofins CDMO: Highly Potent Drug Developm... High-potency drugs present numerous opportunities for improved drug selectivity, efficacy and safety profiles, and represent a growing area of global development focus, for applications such as oncology … more ➔
Over 800 Participants from 40 Countries in...Six times as many decision-makers attended the 3rd European Chemistry Partnering today- compared to the initial event two years ago: with participants from Brazil, Morocco and Australia, all six continents … more ➔
Goodfellow helps international companies f... Leading global supplier of materials, Goodfellow, has collaborated with a number of major international companies to provide research materials in several industry sectors. more ➔
DIA Europe 2019: Why attend? DIA Europe is more than a traditional meeting. It’s a chance to learn, engage, and grow as a healthcare professional alongside thousands of cross-functional collaborative leaders. more ➔